5751 - 5800 of 9148 Results
Title
Year
-
OPENTitle: Regional cortical network atrophy predicts progression to dementia in the Lewy body diseasesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 12Start Page: e70963End Page: e70963Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.70963Best OA location URL: https://doi.org/10.1002/alz.70963Citation Count: 0
-
OPENTitle: Joint modeling of multivariate longitudinal data and survival data in several observational studies of Huntington’s diseaseJournal Name: BMC Medical Research MethodologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page: 138End Page: 138Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12874-018-0592-9Best OA location URL: https://bmcmedresmethodol.biomedcentral.com/track/pdf/10.1186/s12874-018-0592-9.pdfCitation Count: 62
- High Stability and Cooperative Unfolding of α-Synuclein Oligomers2014RESTRICTEDTitle: High Stability and Cooperative Unfolding of α-Synuclein OligomersJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 53Issue #: 39Start Page: 6252End Page: 6263Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/bi5007833Citation Count: 75
-
OPENTitle: Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: a Methodological WorkflowJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 93Issue #: 32Start Page: 11108End Page: 11115Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acs.analchem.1c01128Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.1c01128Citation Count: 8
-
OPENTitle: Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmosetJournal Name: European Journal of NeurosciencePublisher: WileyVol: 60Issue #: 9Start Page: 6175End Page: 6184Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ejn.16454Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.16454Citation Count: 3
-
OPENTitle: Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primatesJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 20Start Page: eaaz9165End Page: eaaz9165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.aaz9165Best OA location URL: https://advances.sciencemag.org/content/advances/6/20/eaaz9165.full.pdfCitation Count: 61
-
OPENTitle: Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and plateletsJournal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of DiseasePublisher: Elsevier BVVol: 1812Issue #: 11Start Page: 1508End Page: 1514Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbadis.2011.07.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3185199Citation Count: 61
-
OPENTitle: Associating Resting-State functional connectivity and improvements in reactive balance in Parkinson’s DiseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 878Issue #:Start Page: 138584End Page: 138584Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2026.138584Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13123762/Citation Count: 0
- Longitudinal evolution of non-motor symptoms according to age at onset in early Parkinson's disease2020RESTRICTEDTitle: Longitudinal evolution of non-motor symptoms according to age at onset in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 418Issue #:Start Page: 117157End Page: 117157Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117157Citation Count: 22
-
OPENTitle: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 3Start Page: 1218End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294Best OA location URL: https://doi.org/10.7270/q280562cCitation Count: 26
-
OPENTitle: Autonomic dysfunction is associated with neuropsychological impairment in Lewy body diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 267Issue #: 7Start Page: 1941End Page: 1951Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-09783-7Best OA location URL: http://hdl.handle.net/10810/65454Citation Count: 29
-
OPENTitle: Validating new symptom emergence as a patient-centric outcome measure for PD clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 128Issue #:Start Page: 107118End Page: 107118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107118Best OA location URL: https://www.prd-journal.com/article/S1353-8020(24)01130-1/pdfCitation Count: 0
- α-synuclein seed amplification in Parkinson's disease – Authors' reply2023OPENTitle: α-synuclein seed amplification in Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 985End Page: 986Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00371-xCitation Count: 7
-
OPENTitle: Identification of small molecule dimethyoxyphenyl piperazine inhibitors of alpha-synuclein fibril growthJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 33108End Page: 33108Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-17658-yBest OA location URL: https://www.nature.com/articles/s41598-025-17658-y.pdfCitation Count: 0
-
RESTRICTEDTitle: Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphismsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 22Issue #:Start Page: 102End Page: 105Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.11.016Best OA location URL: http://doi.org/10.1016/j.parkreldis.2015.11.016Citation Count: 21
-
RESTRICTEDTitle: Multiple system atrophy and apolipoprotein EJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 647End Page: 650Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27297Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5889322Citation Count: 23
- Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates2015RESTRICTEDTitle: Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological CorrelatesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 27Issue #: 1Start Page: 121End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.5b00529Citation Count: 18
-
OPENTitle: Common and rare variants in HFE are not associated with Parkinson's disease in EuropeansJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 107Issue #:Start Page: 174End Page: 177Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.05.019Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8595489Citation Count: 3
- Constructing treatment episodes from concomitant medication logs: a prospective observational study2020OPENTitle: Constructing treatment episodes from concomitant medication logs: a prospective observational studyJournal Name: BMJ OpenPublisher: BMJVol: 10Issue #: 3Start Page: e034305End Page: e034305Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2019-034305Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/10/3/e034305.full.pdfCitation Count: 4
-
OPENTitle: Dysregulated dopamine storage increases the vulnerability to α-synuclein in nigral neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 47Issue #: 3Start Page: 367End Page: 377Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2012.05.012Best OA location URL: https://zenodo.org/record/3420973Citation Count: 57
-
OPENTitle: VGLUT2 in Parkinson’s disease: an emerging therapeutic targetJournal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 30Issue #: 2Start Page: 103End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/14728222.2026.2619754Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12853294/Citation Count: 0
-
OPENTitle: Quantifying Spatiotemporal Gait Parameters with HoloLens in Healthy Adults and People with Parkinson’s Disease: Test-Retest Reliability, Concurrent Validity, and Face ValidityJournal Name: SensorsPublisher: MDPI AGVol: 20Issue #: 11Start Page: 3216End Page: 3216Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/s20113216Best OA location URL: https://www.mdpi.com/1424-8220/20/11/3216/pdf?version=1591769863Citation Count: 49
- Profiling the Braak progression in Parkinson’s disease: a transcriptomics and ML driven identification of progressive biomarker and prognostic ceRNA signature2025RESTRICTEDTitle: Profiling the Braak progression in Parkinson’s disease: a transcriptomics and ML driven identification of progressive biomarker and prognostic ceRNA signatureJournal Name: NeurosciencePublisher: Elsevier BVVol: 593Issue #:Start Page: 41End Page: 55Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2025.12.011Citation Count: 3
- Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations2026OPENTitle: Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitationsJournal Name: Acta Pharmaceutica Sinica BPublisher: Elsevier BVVol: 16Issue #: 5Start Page: 2645End Page: 2681Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.apsb.2026.03.031Best OA location URL: https://doi.org/10.1016/j.apsb.2026.03.031Citation Count: 0
- Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease2018RESTRICTEDTitle: Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 642End Page: 646Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27300Best OA location URL: http://doi.org/10.1002/mds.27300Citation Count: 155
-
OPENTitle: Assessment of an Objective Method of Dyskinesia Measurement in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 160End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12583Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12583Citation Count: 4
- Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain Tissue2020RESTRICTEDTitle: Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain TissueJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 17Start Page: 2679End Page: 2687Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00336Citation Count: 16
-
OPENTitle: Shortening the SWAL-QOL: Is it possible to create a valid short form?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 148Issue #:Start Page: 108362End Page: 108362Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2026.108362Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13225615/Citation Count: 0
-
OPENTitle: Prospective longitudinal cohort of Argentinean patients with progressive supranuclear palsy and corticobasal syndrome: A platform for epidemiological and translational researchJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100339End Page: 100339Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100339Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100339Citation Count: 0
-
OPENTitle: Mitoepigenetic Alterations in Early-Onset Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 27Issue #: 4Start Page: 2033End Page: 2033Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms27042033Best OA location URL: https://www.mdpi.com/1422-0067/27/4/2033/pdfCitation Count: 0
-
OPENTitle: Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 119Issue #:Start Page: 105954End Page: 105954Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105954Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10903276/pdf/nihms-1966735.pdfCitation Count: 3
- Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 12023OPENTitle: Loss of parkin causes endoplasmic reticulum calcium dyshomeostasis by upregulation of reticulocalbin 1Journal Name: European Journal of NeurosciencePublisher: WileyVol: 57Issue #: 5Start Page: 739End Page: 761Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ejn.15917Citation Count: 6
-
OPENTitle: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic StimulationJournal Name: ResearchPublisher: American Association for the Advancement of Science (AAAS)Vol: 2019Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2019/7109535Best OA location URL: https://doi.org/10.1155/2019/7109535Citation Count: 2
- Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity2016OPENTitle: Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease SeverityJournal Name: Oxidative Medicine and Cellular LongevityPublisher: WileyVol: 2016Issue #: 1Start Page: 9409363End Page: 9409363Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2016/9409363Best OA location URL: http://downloads.hindawi.com/journals/omcl/2016/9409363.pdfCitation Count: 93
-
OPENTitle: Sacral nerve stimulation improves gait in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 4Start Page: 1075End Page: 1076Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.03.074Best OA location URL: https://doaj.org/article/1a3d778a5f164f45882a79a2adfcbf97Citation Count: 0
- Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Anti-parkinsonian effect of the mGlu2 positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmosetJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 939Issue #:Start Page: 175429End Page: 175429Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2022.175429Citation Count: 6
-
OPENTitle: Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisitedJournal Name: Human Brain MappingPublisher: WileyVol: 37Issue #: 7Start Page: 2547End Page: 2556Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23192Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.23192Citation Count: 81
-
OPENTitle: Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 49End Page: 59Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.196Best OA location URL: https://doi.org/10.1016/j.jalz.2019.08.196Citation Count: 46
-
OPENTitle: The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stressJournal Name: Redox BiologyPublisher: Elsevier BVVol: 19Issue #:Start Page: 62End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2018.07.021Best OA location URL: https://doi.org/10.1016/j.redox.2018.07.021Citation Count: 93
- Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?2022RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 20
-
OPENTitle: Intramolecular Povarov Reactions for the Synthesis of Chromenopyridine Fused 2-Pyridone Polyheterocycles Binding to α-Synuclein and Amyloid-β FibrilsJournal Name: The Journal of Organic ChemistryPublisher: American Chemical Society (ACS)Vol: 85Issue #: 21Start Page: 14174End Page: 14189Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.joc.0c01699Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.joc.0c01699Citation Count: 23
-
OPENTitle: Olfaction in Neuropathologically Defined Progressive Supranuclear PalsyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1700End Page: 1704Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28568Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9972484Citation Count: 19
- Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes2024OPENTitle: Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 7Start Page: 2308End Page: 2324Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awae069Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae069/56831321/awae069.pdfCitation Count: 43
-
OPENTitle: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 142Issue #: 3Start Page: 495End Page: 511Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02324-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-021-02324-0.pdfCitation Count: 161
-
OPENTitle: A Modified Reading the Mind in the Eyes Test Predicts Behavioral Variant Frontotemporal Dementia Better Than Executive Function TestsJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00011Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00011/pdfCitation Count: 43
- Freezing of gait and levodopa2021OPENTitle: Freezing of gait and levodopaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 505End Page: 506Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00175-7Citation Count: 8
-
OPENTitle: AI-Validated Brain Targeted mRNA Lipid Nanoparticles with Neuronal TropismJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 19Issue #: 41Start Page: 36106End Page: 36128Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acsnano.4c15013Best OA location URL: https://doi.org/10.1021/acsnano.4c15013Citation Count: 30
- A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitro2015RESTRICTEDTitle: A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitroJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 607Issue #:Start Page: 83End Page: 89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.09.015Citation Count: 51
-
OPENTitle: Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activityJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 9Issue #: 11Start Page: 1295End Page: 1305Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.025684Best OA location URL: http://dmm.biologists.org/content/dmm/9/11/1295.full.pdfCitation Count: 69
- Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamine2017RESTRICTEDTitle: Methamphetamine‐induced mitochondrial oxidant stress mediated by monoamine oxidase metabolism of dopamineJournal Name: The FASEB JournalPublisher: WileyVol: 31Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.31.1_supplement.987.3Citation Count: 3